Company
IR-Med, Inc.
IR-Med Inc. develops infrared spectroscopy and AI-based point-of-care devices for detecting and monitoring medical conditions such as pressure injuries and diabetic ulcers.
IR-Med, Inc. is a publicly traded company. Leadership tracked by CEOInsider includes Yaniv Cohen (CEO).
Leadership
Current
Recent developments
AI summary of recent coverageRecent coverage of IR-Med has focused on a leadership transition, with co-founder Yaniv Cohen named interim CEO, alongside the company's international expansion efforts and clinical advancement of its medical devices. The coverage highlights a collaboration with Dice Technologies to evaluate IR-Med's pressure-injury prevention platform in Japan and the launch of a first-in-human clinical trial for its DiaSafe device aimed at diabetic foot ulcer assessment. The company has also received recognition for its health technology innovation in the competitive medical device sector.
Summarized from the headlines in the sidebar; see each source for the full story.